Nutritional management for cognitive symptoms after COVID-19
Nutritional Management of Post COVID-19 Cognitive Symptoms
This study is testing whether taking medium chain triglyceride oil can help improve brain fog in people aged 22-50 who are dealing with long COVID symptoms.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 100 (estimated) |
| Ages | 22 Years to 50 Years |
| Sex | All |
| Sponsor | University of Alberta Academic / other |
| Locations | 1 site (Edmonton, Alberta) |
| Trial ID | NCT05705648 on ClinicalTrials.gov |
What this trial studies
This clinical trial aims to investigate cognitive complaints, often referred to as 'brain fog', in individuals aged 22-50 who have experienced long COVID. Participants will be randomly assigned to receive either medium chain triglyceride oil or safflower oil daily, and their cognitive function will be assessed through brain testing and questionnaires. The study seeks to determine the natural progression of these cognitive symptoms and the potential effects of the dietary oils on improving them.
Who should consider this trial
Good fit: Ideal candidates are individuals aged 22-50 who have had a confirmed COVID-19 infection at least three months prior and are experiencing ongoing cognitive complaints.
Not a fit: Patients with pre-existing cognitive complaints or medical conditions affecting cognitive function may not benefit from this study.
Why it matters
Potential benefit: If successful, this study could provide insights into effective nutritional interventions for alleviating cognitive symptoms in long COVID patients.
How similar studies have performed: While there is ongoing research into cognitive symptoms post-COVID, this specific approach using nutritional oils is relatively novel and has not been extensively tested.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * confirmed COVID infection, at least 3 months previously, with ongoing cognitive complaints * all other medical conditions stable, and on stable doses of medications (if required) Exclusion Criteria: * COVID infection not confirmed by PCR or Rapid test * unable to speak English * pre-COVID cognitve complaints, and/or medical diagnoses affecting cognitive function
Where this trial is running
Edmonton, Alberta
- University of Alberta — Edmonton, Alberta, Canada (Recruiting)
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.